These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23101271)

  • 1. Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
    Mashayekhi F; Salehi Z; Jamalzadeh HR
    Acta Medica (Hradec Kralove); 2012; 55(2):83-6. PubMed ID: 23101271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
    Salehi Z; Mashayekhi F
    J Clin Neurosci; 2009 Jan; 16(1):90-3. PubMed ID: 19017558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of brain-derived neurotrophic factor (BDNF) in cerebrospinal fluid and plasma of children with meningitis and encephalitis/encephalopathy.
    Morichi S; Kashiwagi Y; Takekuma K; Hoshika A; Kawashima H
    Int J Neurosci; 2013 Jan; 123(1):17-23. PubMed ID: 22900512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
    Frota ER; Rodrigues DH; Donadi EA; Brum DG; Maciel DR; Teixeira AL
    Neurosci Lett; 2009 Aug; 460(2):130-2. PubMed ID: 19477225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis.
    Mashayekhi F; Salehi Z
    J Clin Neurosci; 2011 Jul; 18(7):951-4. PubMed ID: 21570299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
    Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
    Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
    Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
    Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia.
    Korhonen L; Riikonen R; Nawa H; Lindholm D
    Neurosci Lett; 1998 Jan; 240(3):151-4. PubMed ID: 9502226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor in patients with multiple sclerosis.
    Sarchielli P; Greco L; Stipa A; Floridi A; Gallai V
    J Neuroimmunol; 2002 Nov; 132(1-2):180-8. PubMed ID: 12417449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
    J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis.
    Yalachkov Y; Anschütz V; Jakob J; Schaller-Paule MA; Schäfer JH; Reiländer A; Friedauer L; Behrens M; Steffen F; Bittner S; Foerch C
    Mult Scler Relat Disord; 2022 Jul; 63():103822. PubMed ID: 35504173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
    Tongiorgi E; Sartori A; Baj G; Bratina A; Di Cola F; Zorzon M; Pizzolato G
    J Neurol Sci; 2012 Sep; 320(1-2):161-5. PubMed ID: 22836016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
    Ou ZA; Byrne LM; Rodrigues FB; Tortelli R; Johnson EB; Foiani MS; Arridge M; De Vita E; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
    Sci Rep; 2021 Feb; 11(1):3481. PubMed ID: 33568689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.